6533b85efe1ef96bd12c09a5

RESEARCH PRODUCT

Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency

Ashley N. SigafoosSalima El ChehadehMarcia C. WillingEla AkayFlorian CherikAnne-marie E. GoyetteVinodh NarayananDiane Masser-fryeCatherine KarimovRhonda E. SchnurRebekah BressiRhys H. ThomasRhys H. ThomasGary D. ClarkTina Barbaro-dieberJill A. RosenfeldCarlos A. BacinoMaria J. Guillen SacotoLaura RussellKristin LindstromCaroline Schluth-bolardXia WangYvonne Hilhorst-hofsteeMarcelo VargasZehua ZhuAsh ZawertonBoris KerenMariëtte J.v. HofferIsabelle MareyAlice PoissonDaphné LehalleMaries JosephGaetan LescaSimon ZwolinskiLaurence PerrinRhoda AkilapaEmilia K. BijlsmaChristel DepienneChristel DepienneChristel DepienneAmélie PitonClaire G. SalterLucie DupuisDaryl A. ScottJolien S. Klein Wassink-ruiterBenjamin CognéMathilde NizonRichard ChangKirsty McwalterMyriam SrourPerrine CharlesAnne-claude TabetNatalie CanhamSylvie OdentCaroline NavaKarl J. ClarkElizabeth J. BhojJonathan LevyKeri RamseyYves AlembikLucia OrtegaSophie Dupuis-girodShoji IchikawaChristine FrancannetMarta BertoliChristèle DubourgEric W. KleeAnge-line BruelSebastien MouttonEmily FassiAnthony VandersteenAbdul HaseebAntonina WojcikPatrick R. BlackburnLynne M. BirdLynne M. BirdPatrick RumpVéronique LefebvreAlma KuechlerSophie NambotKeren MacholCyril MignotAndreas HartmannRossana Sanchez RussoErica H. GerkesSylvie JaillardRoberto Mendoza-londonoTrevor ColePauline Monin

subject

MaleMedizinHaploinsufficiencyL-SOX5VARIANTS0302 clinical medicineNeurodevelopmental disorderIntellectual disabilityMissense mutation2.1 Biological and endogenous factorsAetiologyChildGenetics (clinical)GeneticsPediatricGenetics & Heredity0303 health sciencesPedigreeFAMILYDNA-Binding Proteinsdevelopmental delayTRANSCRIPTION FACTORSPhenotypeintellectual disabilityChild Preschoolmissense variantsFemalemissense variants.HaploinsufficiencySOXD Transcription FactorsAdultEXPRESSIONAdolescentIntellectual and Developmental Disabilities (IDD)Clinical SciencesMutation MissenseautismCell fate determinationBiologyLONG FORMSEQUENCEArticle03 medical and health sciencesYoung AdultRare DiseasesClinical ResearchCARTILAGEIntellectual DisabilitymedicineGeneticsAnimalsHumansLanguage Development DisordersGenetic Predisposition to DiseasePreschoolTranscription factorGene030304 developmental biology[SDV.GEN]Life Sciences [q-bio]/GeneticsMUTATIONSHuman GenomeInfantmedicine.diseaseBrain DisordersNeurodevelopmental DisordersDeciphering Developmental Disorder StudyMutationAutismepilepsyMissense030217 neurology & neurosurgeryGENERATION

description

International audience; PURPOSE: Lamb-Shaffer syndrome (LAMSHF) is a neurodevelopmental disorder described in just over two dozen patients with heterozygous genetic alterations involving SOX5, a gene encoding a transcription factor regulating cell fate and differentiation in neurogenesis and other discrete developmental processes. The genetic alterations described so far are mainly microdeletions. The present study was aimed at increasing our understanding of LAMSHF, its clinical and genetic spectrum, and the pathophysiological mechanisms involved.METHODS: Clinical and genetic data were collected through GeneMatcher and clinical or genetic networks for 41 novel patients harboring various types of SOX5 alterations. Functional consequences of selected substitutions were investigated.RESULTS: Microdeletions and truncating variants occurred throughout SOX5. In contrast, most missense variants clustered in the pivotal SOX-specific high-mobility-group domain. The latter variants prevented SOX5 from binding DNA and promoting transactivation in vitro, whereas missense variants located outside the high-mobility-group domain did not. Clinical manifestations and severity varied among patients. No clear genotype-phenotype correlations were found, except that missense variants outside the high-mobility-group domain were generally better tolerated.CONCLUSIONS:This study extends the clinical and genetic spectrum associated with LAMSHF and consolidates evidence that SOX5 haploinsufficiency leads to variable degrees of intellectual disability, language delay, and other clinical features.

10.1038/s41436-019-0657-0https://doi.org/10.1038/s41436-019-0657-0